TY - JOUR
T1 - Metastatic Bronchioloalveolar Carcinoma and Metastatic Adenocarcinoma of the Lung
T2 - Comparison of Clinical Manifestations, Chemotherapeutic Responses, and Prognosis
AU - FELDMAN, EDWARD R.
AU - EAGAN, ROBERT T.
AU - SCHAID, DANIEL J.
PY - 1992
Y1 - 1992
N2 - Between 1975 and 1985, 25 patients with metastatic bronchioloalveolar carcinoma and 223 patients with metastatic adenocarcinoma of the lung received experimental cisplatin-based chemotherapy at the Mayo Clinic. The chemotherapeutic response rates were 32% and 33%, respectively. The median times to progression of disease were identical (3 months in both groups). The median survival times were 4 months and 6 months, respectively. Metastatic bronchioloalveolar carcinoma is an aggressive disease that is associated with a poor prognosis, similar to metastatic adenocarcinoma of the lung.
AB - Between 1975 and 1985, 25 patients with metastatic bronchioloalveolar carcinoma and 223 patients with metastatic adenocarcinoma of the lung received experimental cisplatin-based chemotherapy at the Mayo Clinic. The chemotherapeutic response rates were 32% and 33%, respectively. The median times to progression of disease were identical (3 months in both groups). The median survival times were 4 months and 6 months, respectively. Metastatic bronchioloalveolar carcinoma is an aggressive disease that is associated with a poor prognosis, similar to metastatic adenocarcinoma of the lung.
UR - http://www.scopus.com/inward/record.url?scp=0026575183&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026575183&partnerID=8YFLogxK
U2 - 10.1016/S0025-6196(12)60273-0
DO - 10.1016/S0025-6196(12)60273-0
M3 - Article
C2 - 1310129
AN - SCOPUS:0026575183
SN - 0025-6196
VL - 67
SP - 27
EP - 32
JO - Mayo Clinic proceedings
JF - Mayo Clinic proceedings
IS - 1
ER -